Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro

The ongoing SARS-CoV-2 pandemic is a global public health emergency posing a high burden on nations’ health care systems and economies. Despite the great effort put in the development of vaccines and specific treatments, no prophylaxis or effective therapeutics are currently available. Nitric oxide...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaberi, Dario, Krambrich, Janina, Ling, Jiaxin, Luni, Chen, Hedenstierna, Göran, Järhult, Josef D., Lennerstrand, Johan, Lundkvist, Åke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505071/
https://www.ncbi.nlm.nih.gov/pubmed/33007504
http://dx.doi.org/10.1016/j.redox.2020.101734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505071/
https://www.ncbi.nlm.nih.gov/pubmed/33007504
http://dx.doi.org/10.1016/j.redox.2020.101734

Ejemplares similares